Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions

E-ISSN： 1873-4286|21|23|3311-3316

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.23, 2015-01, pp. : 3311-3316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of Borderline Personality Disorder: A Systematic Review

Current Medicinal Chemistry, Vol. 18, Iss. 22, 2011-08 ,pp. : 3322-3329

Bentham Science Publishers

Access to resources Recommend Favorite

Opioid addiction and borderline personality disorder

American Journal on Addictions, Vol. 27, Iss. 1, 2018-01 ,pp. : 54-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pitfalls of clinical trials on pharmacological treatment for obstructive sleep apnoea: future directions

By Kohler Malcolm Stradling John R

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1033-1037

Informa Healthcare

Access to resources Recommend Favorite

Responding to treatment dropout: A review of controlled trials and suggested future directions

By Pulford Justin Adams Peter Sheridan Janie

Addiction Research and Theory, Vol. 18, Iss. 3, 2010-01 ,pp. : 298-315

Informa Healthcare

Access to resources Recommend Favorite